CHRISTINA MCCOY: Open Payments
NPI 1912252354 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,211 in 58 payments from 10 companies in 2025. Trend: 2023 $1,553 · 2024 $1,523 · 2025 $1,211
Food & beverage: $1,211
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $403 |
| Novo Nordisk Inc | 12 | $342 |
| Lilly USA, LLC | 11 | $197 |
| GlaxoSmithKline, LLC. | 4 | $65 |
| Abbott Laboratories | 3 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $47 |
| PFIZER INC. | 3 | $43 |
| Cepheid | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| ABBVIE INC. | 1 | $16 |
Products named: AIRSUPRA, Ozempic, MOUNJARO, BREZTRI, Wegovy, TRELEGY ELLIPTA, FARXIGA, Rybelsus.
Industry payments across TN — which companies pay providers there.
